Emergent BioSolutions Inc. - Director's Dealing 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-04-27

Reporting Person: Richard Ronald (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-27	Common Stock	M	7893	$20.08	Acquired	24288	Direct
2020-04-27	Common Stock	S	7893	$78	Disposed	16395	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-27	Stock Options (Right to Buy)	$20.08	M	7893	Disposed	2021-05-19	Common Stock (7893.0)	Direct

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: Consists of options granted under the company's stock incentive plan as amended and restated.

F3: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.